Mon Sep 22 20:50:00 UTC 2025: Here’s a news article summarizing the provided text:

**Johnson & Johnson Named One of Top Dividend Stocks Despite Focus on AI Growth**

NEW YORK, NY – September 21, 2023 – Healthcare giant Johnson & Johnson (NYSE:JNJ) has been recognized as one of the “12 Best Dividend Paying Stocks to Buy Now,” highlighting its consistent dividend growth and established position in the pharmaceutical and medical device industries. With a market capitalization nearing $425 billion, J&J reported strong second-quarter results, including a 5.8% revenue increase and an 18% rise in earnings.

The company recently spun off its consumer healthcare division, Kenvue, which housed brands like Tylenol and Band-Aid. J&J now focuses on its robust portfolio of immunology and cancer treatments, including popular drugs like Stelara, Tremfya, Darzalex, and Erleada. The company also has 40 programs in late-stage clinical trials, indicating a commitment to future growth through new drug development and expanded approvals for existing treatments.

Johnson & Johnson’s appeal to income investors stems from its impressive 63-year track record of dividend growth. The company currently pays a quarterly dividend of $1.30 per share, resulting in a dividend yield of 2.95% as of September 19.

However, some analysts suggest that while J&J offers a stable dividend, other investments, particularly in the rapidly evolving field of Artificial Intelligence, may offer greater potential returns with potentially lower downside risk. Investors are encouraged to explore options in the AI sector for significant growth opportunities.

Read More